Author

Jenny Stroh

University of Cologne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1

Frequent Co-Authors

Silvia von KarstedtiD· 2 shared Albert Mao LiiD· 1 shared Alexandros P. DrainasiD· 1 shared Ali Taleb AbdallahiD· 1 shared Àlvaro Quintanal-VillalongaiD· 1 shared Andrea C. ChaikovskyiD· 1 shared Anna Edenhofer· 1 shared Anna Schmitt· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Silvia von KarstedtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell state-specific metabolic networks govern ferroptosis versus apoptosis in small cell lung cancer

Jun W. Kim, Christina M. Bebber, Yuqin Dai, Sarah Bopp, Anna Edenhofer, Albert Mao Li, Thomas N. Rösner, Lena Berning, Ming Yang, Logan B. Leak, Jenny Stroh, Bindesh Shrestha, Ali Taleb Abdallah, Dimitrios Prymidis, Hernando J. Olivos, , Julien Sage

The paper identifies metabolic differences between ASCL1-high and low SCLC cells, showing that ASCL1-high cells resist ferroptosis via BH4/BH2 antioxidants and are vulnerable to combined cysteine depletion and BH4/BH2 inhibition.

bioRxiv · Mar 31, 2026 · PreprintCancer Biology

Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes

Christina Bebber, Emily Thomas, Zhiyi Chen, Jenny Stroh, Ariadne Androulidaki, Anna Schmitt, Michaela Hoehne, Lukas Stueker, Marcel Dammert, Fatma Parmaksiz, Cleidson de Padua Alves, Armin Khonsari, Filippo Beleggia, Martin Sos, Jan Riemer, , Silvia von Karstedt

The paper identifies ferroptosis sensitivity as a distinguishing feature of non-neuroendocrine SCLC subtypes and shows that combining ferroptosis induction with TRX pathway inhibition can selectively kill both non-NE and NE SCLC tumors.

Nature Communications · Apr 6, 2021Peer-reviewedCancer Biology